Interactive Clinical Case

This clinical case was presented at 

2017 Annual Conference in multiple sclerosis 

organized by Excemed on March 3 2017 in Rome, Italy.

Today differential diagnosis between MS and other autoimmune disorders of the central nervous system is becoming more and more relevant, as new therapies are emerging. Biomarkers suitable to precisely identify MS patients are not yet available and the risk of misdiagnosis is high. Therefore, in those cases in which there is unexpected reactivation during treatment, the diagnosis should be redefined, as in the case presented here.

High-quality care for improved patient outcomes